# Heron Therapeutics, Inc. (HRTX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/hrtx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from days to weeks following just a single administration. Among its commercialized products is SUSTOL (granisetron), an extended-release injectable designed to prevent both immediate and delayed nausea and...

## Quote & Key Metrics

As of 2026-10-28:

| Metric | Value |
|---|---|
| Price | $0.31 USD |
| Market Cap | $58.6M |
| P/E (TTM) | — |
| EPS (TTM) | −$0.14 |
| 52-Week Range | $0.26 – $1.58 |
| Dividend Yield (TTM) | — |

## Dividend

HRTX has no dividend payment history in our records.

## Frequently Asked Questions

### What does Heron Therapeutics, Inc. do?

Heron Therapeutics, Inc. (HRTX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is HRTX's market cap?

Heron Therapeutics, Inc. (HRTX) has a market capitalization of approximately $58.6 million, as of October 28, 2026, based on the most recent share price and shares outstanding.

### Does HRTX pay a dividend?

No, Heron Therapeutics, Inc. (HRTX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is HRTX profitable?

Heron Therapeutics, Inc. (HRTX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has HRTX ever paid a dividend?

No. Dividend Data's records show no dividend payments from Heron Therapeutics, Inc. (HRTX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/hrtx
- Dividend history & safety: https://www.dividenddata.com/stocks/hrtx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/hrtx/earnings
- Financial statements: https://www.dividenddata.com/stocks/hrtx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/hrtx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/hrtx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.